title: CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate.
authors: M
authors: M
authors: Bocchia
authors: M
authors: M
authors: Ippoliti
authors: A
authors: A
authors: Gozzetti
authors: E
authors: E
authors: Abruzzese
authors: S
authors: S
authors: Calabrese
authors: M
authors: M
authors: Amabile
authors: M T
authors: MT
authors: Pirrotta
authors: R
authors: R
authors: Crupi
authors: D
authors: D
authors: Tozzuoli
authors: M M
authors: MM
authors: Trawinska
authors: M
authors: M
authors: Defina
authors: G
authors: G
authors: Martinelli
authors: F
authors: F
authors: Lauria
mesh_terms: D000328:Adult; D000368:Aged; D001549:Benzamides; D001853:Bone Marrow / Q000473:pathology; D002452:Cell Count; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate